These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33141426)

  • 1. URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors.
    Chavira-Ramos K; Orozco-Morales M; Karasu Ç; Tinkov AA; Aschner M; Santamaría A; Colín-González AL
    Neurotox Res; 2021 Apr; 39(2):146-155. PubMed ID: 33141426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide Reduces the Toxic Synergism Exerted by Quinolinic Acid and Glutaric Acid in Rat Brain Neuronal Cells.
    Kotlar I; Rangel-López E; Colonnello A; Aguilera-Portillo G; Serratos IN; Galván-Arzate S; Pedraza-Chaverri J; Túnez I; Wajner M; Santamaría A
    Neuroscience; 2019 Mar; 401():84-95. PubMed ID: 30668975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices.
    Maya-López M; Rubio-López LC; Rodríguez-Alvarez IV; Orduño-Piceno J; Flores-Valdivia Y; Colonnello A; Rangel-López E; Túnez I; Prospéro-García O; Santamaría A
    Neurotox Res; 2020 Jan; 37(1):126-135. PubMed ID: 31286434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmacological Inhibition of Fatty Acid Amide Hydrolase Prevents Excitotoxic Damage in the Rat Striatum: Possible Involvement of CB1 Receptors Regulation.
    Aguilera-Portillo G; Rangel-López E; Villeda-Hernández J; Chavarría A; Castellanos P; Elmazoglu Z; Karasu Ç; Túnez I; Pedraza G; Königsberg M; Santamaría A
    Mol Neurobiol; 2019 Feb; 56(2):844-856. PubMed ID: 29802570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain.
    Rangel-López E; Colín-González AL; Paz-Loyola AL; Pinzón E; Torres I; Serratos IN; Castellanos P; Wajner M; Souza DO; Santamaría A
    Neuroscience; 2015 Jan; 285():97-106. PubMed ID: 25446347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J; Barna I; Barsvari B; Gyimesi Pelczer K; Yasar S; Panlilio LV; Goldberg S
    Psychopharmacology (Berl); 2009 Jul; 204(4):607-16. PubMed ID: 19259645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
    Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model.
    Nazıroğlu M; Taner AN; Balbay E; Çiğ B
    Mol Cell Biochem; 2019 Mar; 453(1-2):143-155. PubMed ID: 30159798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats.
    Maya-López M; Ruiz-Contreras HA; de Jesús Negrete-Ruíz M; Martínez-Sánchez JE; Benítez-Valenzuela J; Colín-González AL; Villeda-Hernández J; Sánchez-Chapul L; Parra-Cid C; Rangel-López E; Santamaría A
    Biomed Pharmacother; 2017 Apr; 88():745-753. PubMed ID: 28157650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
    Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
    Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Redox Biol; 2018 May; 15():41-50. PubMed ID: 29197803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.